1. Certolizumab pegol treatment in axial spondyloarthritis mitigates fat lesion development: 4-year post-hoc MRI results from a phase 3 study. (15th November 2021) Authors: Baraliakos, Xenofon; Kruse, Sebastian; Auteri, Simone E; de Peyrecave, Natasha; Nurminen, Tommi ; Kumke, Thomas; Hoepken, Bengt; Braun, Jürgen Journal: Rheumatology Issue: Volume 61:Number 7(2022) Page Start: 2875 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗